NFE2L2 and Parkinson disease: A transgenic AD mouse model revealed a decreased toxicity after either adenoviral Nrf2 expression or tert-butylhydroquinone stimulation of Nrf2, in addition to Nrf2 activation being neuroprotective in the previously reported PD models [88].